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Background: The microorganisms intended for use as probiotics in aquaculture should exert antimicrobial activity
and be regarded as safe not only for the aquatic hosts but also for their surrounding environments and humans.
The objective of this work was to investigate the antimicrobial/bacteriocin activity against fish pathogens, the
antibiotic susceptibility, and the prevalence of virulence factors and detrimental enzymatic activities in 99 Lactic
Acid Bacteria (LAB) (59 enterococci and 40 non-enterococci) isolated from aquatic animals regarded as human food.
Results: These LAB displayed a broad antimicrobial/bacteriocin activity against the main Gram-positive and
Gram-negative fish pathogens. However, particular safety concerns based on antibiotic resistance and virulence
factors were identified in the genus Enterococcus (86%) (Enterococcus faecalis, 100%; E. faecium, 79%). Antibiotic
resistance was also found in the genera Weissella (60%), Pediococcus (44%), Lactobacillus (33%), but not in
leuconostocs and lactococci. Antibiotic resistance genes were found in 7.5% of the non-enterococci, including the
genera Pediococcus (12.5%) and Weissella (6.7%). One strain of both Pediococcus pentosaceus and Weissella cibaria
carried the erythromycin resistance gene mef(A/E), and another two P. pentosaceus strains harboured lnu(A)
conferring resistance to lincosamides. Gelatinase activity was found in E. faecalis and E. faecium (71 and 11%,
respectively), while a low number of E. faecalis (5%) and none E. faecium exerted hemolytic activity. None
enterococci and non-enterococci showed bile deconjugation and mucin degradation abilities, or other detrimental
enzymatic activities.
Conclusions: To our knowledge, this is the first description of mef(A/E) in the genera Pediococcus and Weissella,
and lnu(A) in the genus Pediococcus. The in vitro subtractive screening presented in this work constitutes a valuable
strategy for the large-scale preliminary selection of putatively safe LAB intended for use as probiotics in aquaculture.
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distribution, and reproduction in any mediumincluding the production intensification, the disease con-
trol and the prevention of the environmental deterioration
[1]. In fish farming, the widespread use of antibiotics as
prophylactic and therapeutic agents to control bacterial
diseases has been associated with the emergence of anti-
biotic resistance in bacterial pathogens and with the alter-
ation of the microbiota of the aquaculture environment
[2,3]. This resulted in the ban of antibiotic usage as animal
growth promoters in Europe and stringent worldwide reg-
ulations on therapeutical antibiotic applications. This sce-
nario has led to an evergrowing interest in the search andCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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within the frame of good husbandry practices, including
adequate hygiene conditions, vaccination programmes
and the use of probiotics, prebiotics and immunostimu-
lants [4-6]. Recently, novel strategies to control bacterial
infections in aquaculture have emerged, such as specific
killing of pathogenic bacteria by bacteriophages, growth
inhibition of pathogen by short-chain fatty acids and poly-
hydroxyalkanoates, and interference with the regulation of
virulence genes (quorum sensing disruption), which have
been reviewed by Defoirdt et al. [7]. With regard to pro-
biotics, they are defined as live microbial adjuncts which
have a beneficial effect on the host by: (i) modifying the
host-associated or ambient microbial community; (ii) im-
proving feed use or enhancing its nutritional value; (iii)
enhancing the host response towards disease; and/or (iv)
improving its environment [8]. To date, most probiotics
proposed as biocontrollers and bioremediation agents for
aquaculture belong to the LAB group (mainly to the ge-
nera Lactobacillus, Lactococcus, Leuconostoc, Enterococcus
and Carnobacterium), to the genera Vibrio, Bacillus, and
Pseudomonas or to the species Saccharomyces cerevisiae
[8,9]. Recently, a probiotic culture (BactocellW, Pediococcus
acidilactici CNCM MA18/5 M) has been authorized for
the first time for use in aquaculture in the European Union.
According to the FAO/WHO [10], the development of
commercial probiotics requires their unequivocal taxo-
nomic identification, as well as their in vitro and in vivo
functional characterization and safety assessment. In
Europe, the European Food Safety Agency (EFSA) pro-
posed a system for a pre-market safety assessment of
selected groups of microorganisms used in food/feed
and the production of food/feed additives leading to a
Qualified Presumption of Safety (QPS) status [11-13].
The QPS approach propose that the safety assessment
of a defined taxonomic group could be made based
on establishing taxonomic identity, body of know-
ledge, possible pathogenicity and commercial end use.
According to the EFSA approach [13], most LAB spe-
cies are included in the QPS list and, therefore, dem-
onstration of their safety only requires confirmation
of the absence of determinants of resistance to anti-
biotics of human and veterinary clinical significance.
However, in the case of enterococci, a more thorough,
strain-specific evaluation is required to assess the risk
associated to their intentional use in the food chain.
In this work, we present the antimicrobial activity
against fish pathogens and the in vitro safety assessment
beyond the QPS approach of a collection of 99 LAB
belonging to the genera Enterococcus, Lactobacillus,
Lactococcus, Leuconostoc, Pediococcus and Weissella,
previously isolated from aquatic animals regarded as
human food [14] and intended for use as probiotics in
aquaculture.Results
Direct antimicrobial activity of the 99 LAB of aquatic
origin
The 99 LAB strains isolated from fish, seafood and fish
products displayed direct antimicrobial activity against, at
least, four of the eight tested indicator microorganisms
(Table 1). The most sensitive indicators were Listonella
anguillarum CECT4344, Ls. anguillarum CECT7199 and
Aeromonas hydrophila CECT5734, followed by Lactococcus
garvieae JIP29-99, Streptococcus iniae LMG14521 and
Streptococcus agalactiae CF01173. On the contrary, Photo-
bacterium damselae CECT626 and Vibrio alginolyticus
CECT521 were the less sensitive indicator microorganisms.
Preliminary safety evaluation of enterococci: presence of
virulence factors, production of gelatinase and hemolysin
and antibiotic susceptibility
Concerning E. faecalis, most of the strains (20 strains,
95%) harboured, at least, one relevant virulence factor:
efaAfs (95%), gelE (71%), or agg (67%) genes (Table 2). A
positive gelatinase reaction was found in 15 E. faecalis
strains (71%) which harboured gelE, from which 12
also harboured agg gene. Only one E. faecalis strain
(E. faecalis SDP10) (5%), harbouring cylLL-cylLS-cylM,
exerted hemolytic activity, while none of the strains
amplified hyl or esp genes. With regard to E. faecium,
20 strains (53%) harboured, at least, one relevant viru-
lence factor: efaAfs (45%), gelE (24%) or agg (8%), but
only 4 strains (11%) exerted gelatinase activity. None
of the E. faecium strains exerted hemolytic activity nor
amplified hyl or esp genes. The results of the antibiotic
susceptibility tests revealed that 39 enterococccal strains
(66%) displayed acquired antibiotic resistance to antibiotics
other than penicillin G, chloramphenicol and high-level
gentamicin. In this respect, 13 E. faecalis strains (62%)
showed acquired resistance to (i) second generation quino-
lones (ciprofloxacin and/or norfloxacin) (12 strains, 57%),
(ii) rifampicin (5 strains, 24%), (iii) nitrofurantoin (5 strains,
24%), (iv) glycopeptides (vancomycin and teicoplanin)
(4 strains, 19%), and/or (v) erythromycin (1 strain,
5%). However, 26 E. faecium strains (68%), including 17
strains that encode virulence factors and nine strains
without these traits, displayed acquired resistance to (i)
erythromycin (14 strains, 37%), (ii) nitrofurantoin (11
strains, 29%), (iii) second generation quinolones (cipro-
floxacin and/or norfloxacin) (10 strains, 26%), (iv) ri-
fampicin (4 strains, 11%), (v) tetracycline (2 strains, 5%),
and/or (vi) glycopeptides (vancomycin and teicoplanin)
(1 strain, 3%). Moreover, multiple antibiotic resistance
(two to six antibiotics) was found in E. faecalis (10
strains, 48%) and, to a lesser extent, in E. faecium (12
strains, 32%) (Table 2). According to the results above,
21 E. faecalis strains were discarded for further studies
based on the presence of virulence factors (8 strains,
Table 1 Origin and direct antimicrobial activity against fish pathogens of LAB isolated from aquatic animals



























Enterococcus faecium BNM58 + + + ++ ++ +++ + -
Weissella cibaria BNM69 + + + +++ +++ +++ - -
Atlantic salmon
(Salmo salar)
Enterococcus faecalis SMF10 + + + ++ +++ ++ - +
SMF28 + + ++ ++ +++ + - +
SMF37 + + + + ++ +++ - +
SMF69 + + ++ ++ +++ +++ + +
SMM67 + + ++ ++ +++ +++ - -
SMM70 + + + + +++ +++ - -
E. faecium SMA1 + + + ++ ++ +++ + -
SMA7 + + + + ++ +++ + +
SMA8 + + + ++ ++ +++ + +
SMA101 + + + ++ +++ ++ + +
SMA102 + + + ++ +++ + + +
SMA310 ++ + + ++ +++ ++ + +
SMA320 ++ + + ++ ++ +++ + +
SMA361 + + + ++ ++ +++ + +
SMA362 + + + ++ ++ +++ + -
SMA384 + + + ++ ++ +++ + -
SMA389 + + + ++ ++ +++ - +
SMF8 + + ++ ++ ++ ++ + -
SMF39 + + ++ ++ ++ +++ + +
Lactobacillus sakei subsp.
carnosus (Lb. carnosus)
SMA17 + - + ++ +++ +++ - -
Lactococcus lactis subsp.
cremoris (L. cremoris)
SMF110 + + + + +++ +++ + +
SMF161 + + + ++ +++ +++ + ++
























Table 1 Origin and direct antimicrobial activity against fish pathogens of LAB isolated from aquatic animals (Continued)
Pediococcus pentosaceus SMF120 ++ ++ ++ ++ +++ +++ - +
SMF130 ++ + ++ ++ +++ +++ - +
SMM73 ++ + + +++ +++ +++ + ++
W. cibaria SMA14 ++ + + ++ +++ +++ + ++
SMA25 + + + +++ +++ +++ - -
Cod (Gadus
morhua)
E. faecalis BCS27 ++ ++ ++ ++ +++ +++ - -
BCS32 + + + + ++ +++ - +
BCS53 + ++ + + +++ +++ + -
BCS67 + + - ++ +++ ++ - +
BCS72 + + + ++ +++ +++ + -
BCS92 + + + ++ +++ ++ + +
E. faecium BCS59 ++ + ++ ++ +++ +++ - +
BCS971 + + + + +++ +++ - +




BCS35 - - + ++ +++ +++ - -
Lc. cremoris BCS251 + + ++ + +++ +++ - +
BCS252 + + ++ + +++ +++ - +
P. pentosaceus BCS46 ++ + ++ +++ +++ +++ - +




E. faecium B13 + + ++ ++ +++ +++ - -
B27 + + + ++ +++ ++ + +
Lb. carnosus B43 + + + ++ +++ +++ - -
P. pentosaceus B5 ++ + ++ ++ +++ +++ - -
B11 ++ + ++ +++ +++ +++ + -
B41 ++ ++ ++ +++ +++ +++ + ++
B260 ++ + ++ ++ +++ +++ - ++
W. cibaria B4620 ++ + ++ ++ +++ +++ - ++
Common ling
(Molva molva)
E. faecium MV5 + + + ++ ++ +++ + +
Common octopus
(Octopus vulgaris)




















Table 1 Origin and direct antimicrobial activity against fish pathogens of LAB isolated from aquatic animals (Continued)
E. faecium P68 ++ + +++ ++ +++ +++ - +
P623 + + + + +++ ++ - +
P. pentosaceus P63 ++ + ++ +++ +++ +++ - +
P621 ++ + ++ + +++ +++ - +
W. cibaria P38 ++ ++ ++ ++ +++ +++ - +
P50 ++ + + ++ +++ +++ - +
P61 ++ + + ++ +++ +++ - -
P64 ++ + + +++ +++ +++ + ++
P69 ++ + + ++ +++ +++ + ++
P71 + + ++ ++ +++ +++ + +
P73 ++ ++ ++ ++ +++ +++ - +




E. faecium LPP29 + + + + ++ +++ + -
P. pentosaceus LPM78 ++ + ++ ++ +++ +++ - -
LPM83 ++ + ++ ++ +++ +++ - -
LPP32 ++ ++ ++ ++ +++ +++ - +
LPV46 ++ + ++ ++ +++ +++ - +
LPV57 ++ + ++ +++ +++ +++ - -
European squid
(Loligo vulgaris)
E. faecium CV1 + + + + +++ +++ - +




E. faecalis GM22 - - + ++ ++ +++ + ++
GM26 - - + + ++ ++ + -
GM33 - - ++ + ++ +++ + -
E. faecium GM23 + + + ++ ++ +++ + +
GM29 ++ ++ + ++ ++ +++ + +
GM351 - - + + ++ ++ + -




E. faecalis CGM16 ++ + ++ ++ +++ +++ - +




















Table 1 Origin and direct antimicrobial activity against fish pathogens of LAB isolated from aquatic animals (Continued)
CGM1514 + + + ++ +++ ++ + +
CGV67 ++ + + + +++ +++ + +
E. faecium CGM171 + + + + +++ +++ + +




E. faecium TPM76 + + + + ++ +++ + +
TPP2 + + + + ++ +++ + +
P. pentosaceus TPP3 ++ + + ++ +++ +++ - ++
Sardine (Sardina
pilchardus)
E. faecalis SDP10 + + + + +++ +++ - +
W. cibaria SDM381 ++ + ++ ++ +++ +++ - -
SDM389 + + ++ ++ +++ +++ - -
Swimcrab (Necora
puber)
E. faecium NV50 + + + ++ ++ ++ + -
NV51 ++ + + + ++ ++ + ++
NV52 ++ + + + ++ +++ + +
NV54 ++ + + + ++ +++ + +
NV56 ++ + + ++ ++ ++ + -
aDirect antimicrobial activity was determined by a SOAT and the scores reflect different degrees of growth inhibition (diameter in mm); -, no inhibition; +, 3–5 mm inhibition zone; ++, 6–9 mm inhibition zone; +++,




















Table 2 Preliminary safety evaluation of enterococci
Enterococcus
spp.
Strain Virulence Factors Antibiotic resistance
phenotypecGenotypea Phenotypeb
E. faecalis SMF10 efaAfs+, gelE+, agg+ GelE+, Hly- CIP, NOR
SMF28 efaAfs+, gelE+ GelE+, Hly- CIP, NOR
SMF37 efaAfs+, gelE+, agg+ GelE+, Hly- -
SMF69 efaAfs+, gelE+, agg+ GelE+, Hly- CIP, RIF
SMM67 n.d. GelE-, Hly- CIP, NIT, NOR, TEC, VAN
SMM70 efaAfs+, gelE+ GelE+, Hly- ERY, NIT
BCS27 efaAfs+, gelE+, agg+ GelE+, Hly- CIP, NIT, NOR, RIF, TEC, VAN
BCS32 efaAfs+, gelE+, agg+ GelE+, Hly- NOR
BCS53 efaAfs+, gelE+, agg+ GelE+, Hly- -
BCS67 efaAfs+ GelE-, Hly- CIP
BCS72 efaAfs+, agg+ GelE-, Hly- -
BCS92 efaAfs+ GelE-, Hly- -
P77 efaAfs+, gelE+ GelE+, Hly- NIT, NOR, RIF, TEC, VAN
GM22 efaAfs+, gelE+, agg+ GelE+, Hly- CIP, NOR
GM26 efaAfs+, gelE+, agg+ GelE+, Hly- -
GM33 efaAfs+, gelE+, agg+ GelE+, Hly- -
CGM156 efaAfs+ GelE-, Hly- CIP, NIT, NOR, RIF, TEC, VAN
CGM1514 efaAfs+, agg+ GelE-, Hly- -
CGM16 efaAfs+, gelE+, agg+ GelE+, Hly- CIP, NOR, RIF
CGV16 efaAfs+, gelE+, agg+ GelE+, Hly- NOR
SDP10 efaAfs+, gelE+, agg+, cylLLLS
+, cylLLLSM
+ GelE+, Hly+ -
E. faecium BNM58 n.d. GelE-, Hly- -
SMA1 n.d. GelE-, Hly- CIP
SMA7 n.d. GelE-, Hly- -
SMA8 n.d. GelE-, Hly- -
SMA101 n.d. GelE-, Hly- ERY, NIT
SMA102 efaAfs+ GelE-, Hly- ERY, NIT
SMA310 n.d. GelE-, Hly- ERY, NIT
SMA320 efaAfs+ GelE-, Hly- ERY, NIT
SMA361 efaAfs+ GelE-, Hly- ERY
SMA362 n.d. GelE-, Hly- ERY, NIT
SMA384 gelE+ GelE-, Hly- NIT
SMA389 gelE+ GelE-, Hly- CIP, NIT, NOR
SMF8 n.d. GelE-, Hly- -
SMF39 efaAfs+, gelE+ GelE-, Hly- -
BCS59 n.d. GelE-, Hly- NIT
BCS971 n.d. GelE-, Hly- ERY
BCS972 n.d. GelE-, Hly- ERY
B13 gelE+ GelE+, Hly- CIP
B27 efaAfs+, gelE+ GelE+, Hly- CIP
MV5 efaAfs+, gelE+, agg+ GelE-, Hly- CIP, NIT
P68 efaAfs+, gelE+, cylLLLS
+ GelE+, Hly- CIP, NIT, NOR, RIF, TEC, VAN
P623 efaAfs+ GelE-, Hly- ERY
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Table 2 Preliminary safety evaluation of enterococci (Continued)
LPP29 n.d. GelE-, Hly- -
CV1 n.d. GelE-, Hly- -
CV2 n.d. GelE-, Hly- -
GM23 efaAfs+ GelE-, Hly- CIP, NOR, RIF, TET
GM29 efaAfs+, gelE+, cylLLLS
+ GelE-, Hly- CIP, NOR, RIF
GM351 efaAfs+, gelE+, agg+ GelE+, Hly- CIP, NOR
GM352 efaAfs+ GelE-, Hly- CIP, NIT, NOR, RIF, TET
CGM171 n.d. GelE-, Hly- ERY
CGM172 efaAfs+ GelE-, Hly- ERY
TPM76 n.d. GelE-, Hly- -
TPP2 n.d. GelE-, Hly- -
NV50 efaAfs+, agg+ GelE-, Hly- -
NV51 efaAfs+ GelE-, Hly- ERY
NV52 n.d. GelE-, Hly- ERY
NV54 efaAfs+ GelE-, Hly- ERY
NV56 efaAfs+ GelE-, Hly- -
an.d., not detected.
bGelE and Hly refer to gelatinase and cytolysin/hemolysin activity, respectively.
cAbbreviation of antibiotics: CIP, ciprofloxacin; ERY, erythromycin; NIT, nitrofurantoin; NOR, norfloxacin; RIF, rifampicin; TEC, teicoplanin; TET, tetracycline;
VAN, vancomycin.
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(12 strains, 57%). Regarding E. faecium strains, 29 (76%)
were dropped from further screening based on acquired
antibiotic resistance (9 strains, 24%), the presence of viru-
lence factors (3 strains, 8%) or both (17 strains, 45%).
Extracellular antimicrobial activity of the 49 pre-selected LAB
The antimicrobial activity of supernatants from the 49
pre-selected LAB (9 E. faecium selected based on their
preliminary safety assessment and 40 non-enterococcal
strains) with direct antimicrobial activity against fish
pathogens was assayed against three indicator microor-
ganisms by an ADT (Table 3). In this regard, 24 (49%) and
10 (20%) strains displayed extracellular antimicrobial ac-
tivity in their supernatants and/or 20-fold concentrated
supernatants against Pediococcus damnosus CECT4797
and L. garvieae JIP 29–99, respectively, but none of the
strains inhibited the Gram-negative strain A. hydrophila
CECT5734. Interestingly, the antimicrobial activity of the
respective supernatants was sensitive to proteinase K treat-
ment, but was not affected by the heat treatment, revealing
the proteinaceous nature and heat stability of the secreted
antimicrobial compounds (i.e., heat-stable bacteriocins).
The 24 LAB strains secreting bacteriocins into the liquid
growth medium belong to the species P. pentosaceus (15
strains), E. faecium (8 strains), and Lb. curvatus (1 strain).
In vitro safety assessment of the 49 pre-selected LAB
The 49 pre-selected LAB were further submitted to a com-
prehensive safety assessment by different in vitro tests.Hemolysin production, bile salts deconjugation and
mucin degradation
None of the non-enterococcal strains showed hemolytic
activity, similarly as found for the 9 enterococci. More-
over, bile salts deconjugation and mucin degradation
abilities were not found in any of the tested strains.Enzymatic activities
The results of the analysis of enzymatic activity profiles
of the tested LAB are shown in Table 4. None of the
strains showed lipolytic activity, except E. faecium
LPP29, TPM76, SMA7, and SMF8 which produced es-
terase (C4) and esterase lipase (C8). Moreover, none of
the LAB strains showed protease activity (trypsin
and α-chymotrypsin). Nevertheless, peptidase activity (leu-
cine, valine or cystine arylamidase) was found in all the
species. All strains showed acid phosphatase (except
E. faecium TPM76 and Lc. cremoris) and naphthol-
AS-BI-phosphohydrolase activities, but none displayed al-
kaline phosphatase activity. β-Galactosidase was found in
most species (but not in all strains) except Lb. curvatus
and L. cremoris. However, α-glucosidase was only found in
the three Lc. cremoris strains. β-Glucosidase and N-
acetyl-β-glucosaminidase activities were observed in most
E. faecium, Lactobacillus spp., L. cremoris, and P. pentosa-
ceus strains, but only in two W. cibaria strains, while the
three Lc. cremoris strains showed β-glucosidase but
lacked N-acetyl-β-glucosaminidase activity. On the other
hand, α-galactosidase, β-glucuronidase, α-mannosidase, and
Table 3 Extracellular antimicrobial activity of the 49 pre-selected LABa
LAB speciesb Strain Indicator microorganisms
P. damnosus CECT4797 L. garvieae JIP29-99 A. hydrophila CECT5734
S CS S CS S CS
Enterococci
E. faecium BNM58 22.4 26.8 14.0 15.0 - -
SMA7 - - - - - -
SMA8 19.0 19.6 9.4 10.2 - -
SMF8 19.0 21.8 10.3 10.8 - -
LPP29 20.5 24.4 12.6 13.1 - -
CV1 15.0 19.2 - - - -
CV2 19.8 23.7 12.7 11.4 - -
TPM76 17.0 21.2 - 8.7 - -
TPP2 19.7 23.5 12.8 12.4 - -
Non-enterococci
Lb. curvatus BCS35 18.2 24.7 - - - -
P. pentosaceus SMF120 - - - - - -
SMF130 7.4 9.7 - - - -
SMM73 - 9.5 - - - -
BCS46 - 9.4 - - - -
B5 8.1 9.0 - - - -
B11 - 9.0 - - - -
B41 7.3 11.7 - - - -
B260 7.3 10.6 - - - -
P63 - 9.8 - - - -
P621 - 10.5 - - - -
LPM78 - 8.3 - - - -
LPM83 7.9 11.0 - - - -
LPP32 8.5 11.3 - 8.9 - -
LPV46 8.2 11.3 - 8.2 - -
LPV57 7.6 10.5 - - - -
TPP3 9.0 11.7 7.5 9.2 - -
aAntimicrobial activity (mm) of supernatants (S) and 20-fold concentrated supernatants (CS) as determined by an ADT.
bLb. carnosus, L. cremoris, Lc. cremoris and W. cibaria strains did not show extracellular antimicrobial activity against any of the tested indicator microorganisms.
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LAB strains.
Antibiotic susceptibility determined by the broth
microdilution test
The distribution of MICs of the tested antibiotics is sum-
marized in Tables 5 and 6. Microbiological breakpoints for
ampicillin, vancomycin, gentamicin, kanamycin, strepto-
mycin, erythromycin, clindamycin, tetracycline, and chlor-
amphenicol reported by the FEEDAP document on the
assessment of bacterial products used as feed additives in
relation to antibiotic resistance [15] were used to categor-
ise the 49 LAB as susceptible or resistant strains. In this
document, the genus Weissella, which is considered agroup of heterofermentative Leuconostoc-like LAB [16], is
not included. For this reason, the respective MICs were
interpreted by using the breakpoints given for the genus
Leuconostoc. Besides, due to the lack of microbiological
breakpoints for penicillin and linezolid on the FEEDAP
document, we interpreted our results on these antibiotics
according to the cut-off levels proposed by Klare et al.
[17] for pediococci, namely 1 and 2 mg/L for penicillin
and linezolid, respectively. According to our results, the
percentages of strains showing antibiotic resistance in
the genera Weissella, Pediococcus, Lactobacillus and
Enterococcus were 60, 44, 33 and 11%, respectively, while
none of the leuconostocs and lactococci showed this
phenotype. In summary, 97.5% of the 40 non-enterococal



























E. faecium BNM58 0 0 ≥40 10 10 20 10 0 0 0 0
SMA7 20 20 ≥40 30 20 30 10 0 0 0 0
SMA8 0 0 ≥40 ≥40 5 5 5 5 0 20 ≥40
SMF8 5 5 10 5 5 20 10 0 0 30 0
LPP29 10 10 30 5 20 10 10 0 0 0 0
CV1 0 0 ≥40 ≥40 5 10 20 20 0 30 ≥40
CV2 0 0 ≥40 ≥40 10 10 20 0 0 10 ≥40
TPM76 30 10 20 0 0 0 10 10 0 0 0
TPP2 0 0 ≥40 20 10 10 10 5 0 30 0
Non-enterococci
Lb. carnosus SMA17 0 0 ≥40 ≥40 0 30 20 30 0 30 30
B43 0 0 ≥40 ≥40 0 5 5 10 0 0 0
Lb. curvatus BCS35 0 0 ≥40 10 5 10 20 0 0 5 10
L. cremoris SMF110 0 0 ≥40 ≥40 0 20 20 0 0 30 30
SMF161 0 0 20 0 5 ≥40 20 0 0 0 0
SMF166 0 0 ≥40 ≥40 0 20 20 0 0 10 10
Lc. cremoris SMM69 0 0 10 0 0 0 10 ≥40 30 ≥40 0
BCS251 0 0 5 0 0 0 5 20 20 10 0
BCS252 0 0 10 0 0 0 10 30 20 10 0
P. pentosaceus SMF120 0 0 ≥40 ≥40 20 ≥40 ≥40 0 0 20 20
SMF130 0 0 ≥40 ≥40 20 30 ≥40 20 0 ≥40 ≥40
SMM73 0 0 ≥40 30 10 20 30 20 0 30 ≥40
BCS46 0 0 ≥40 ≥40 5 20 30 30 0 ≥40 ≥40
B5 0 0 30 ≥40 10 10 20 10 0 30 ≥40
B11 0 0 ≥40 30 0 5 20 0 0 30 ≥40
B41 0 0 30 ≥40 0 5 20 5 0 20 ≥40
B260 0 0 ≥40 ≥40 10 20 30 0 0 20 30
P63 0 0 ≥40 ≥40 5 20 20 30 0 30 ≥40
P621 0 0 ≥40 ≥40 0 5 30 0 0 30 ≥40




















Table 4 Enzymatic activity profiles of the 49 pre-selected LABa (Continued)
LPM83 0 0 30 30 5 10 20 30 0 10 ≥40
LPP32 0 0 ≥40 ≥40 5 5 20 0 0 30 ≥40
LPV46 0 0 ≥40 ≥40 5 20 30 5 0 30 30
LPV57 0 0 ≥40 ≥40 5 20 30 30 0 ≥40 ≥40
TPP3 0 0 ≥40 ≥40 5 5 5 10 0 0 0
W. cibaria BNM69 0 0 0 0 0 30 10 30 0 0 0
SMA14 0 0 0 0 0 20 5 10 0 0 0
SMA25 0 0 ≥40 ≥40 0 30 20 ≥40 0 30 30
BCS50 0 0 0 0 0 30 20 30 0 0 0
B4620 0 0 20 20 0 30 20 30 0 5 5
P38 0 0 0 0 0 ≥40 20 ≥40 0 0 0
P50 0 0 0 0 0 ≥40 20 0 0 0 0
P61 0 0 0 0 0 20 10 0 0 0 0
P64 0 0 0 0 0 30 10 0 0 0 0
P69 0 0 0 0 0 ≥40 20 ≥40 0 0 0
P71 0 0 0 0 0 ≥40 10 0 0 0 0
P73 0 0 0 0 0 30 20 30 0 0 0
P622 0 0 0 0 0 ≥40 10 0 0 0 0
SDM381 0 0 10 5 0 20 10 30 0 0 0
SDM389 0 0 0 0 0 ≥40 20 ≥40 0 0 0
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http://www.biomedcentral.com/1471-2180/13/15strains resulted susceptible to ampicillin, 100% to gentami-
cin, 72.5% to kanamycin, 100% to streptomycin, 95% to
erythromycin, 87.5% to clindamycin, 95% to tetracycline,
and 100% to chloramphenicol. For vancomycin, it is
known that facultative and obligate heterofermentative
Lactobacillus, Pediococcus spp. and Leuconostoc spp. are
intrinsically resistant. In contrast, the three lactococci
were clearly susceptible to these antibiotics, showing a
MIC of 0.5 mg/L. On the other hand, according to the
cut-off values proposed by Klare et al. [17], 93% of P.
pentosaceus strains were susceptible to penicillin and line-
zolid. With regard to E. faecium, all the tested strains were
susceptible to ampicillin, vancomycin, gentamicin, kana-
mycin, streptomycin, tetracycline, chloramphenicol, and
erythromycin except E. faecium BNM58 against the latter
antibiotic (MIC = 8 mg/L). Moreover, multiple antibiotic
resistance (three antibiotics) was only detected in P.
pentosaceus LPM78 (6.2%) andW. cibaria SMA25 (6.7%).
Detection of antibiotic resistance genes
The non-enterococcal strains showing antibiotic resistances
in the VetMIC assays (17 strains) were further submitted to
PCR in order to identify the presence of the respective anti-
biotic resistance genes. The tested strains were the follow-
ing: Lb. carnosus B43 (ampicillin resistant), P. pentosaceus
TPP3 and SMF120 (tetracycline resistant), P. pentosaceus
LPP32, LPM83 and B5 (clindamycin resistant), P. pentosa-
ceus LPV57 and W. cibaria P50, P61, P64, P73, SDM381,
SDM389, SMA14 and BCS50 (kanamycin resistant), and
P. pentosaceus LPM78 and W. cibaria SMA25 (kanamy-
cin, erythromycin and clindamycin resistant). Acquired
antibiotic resistances likely due to added genes were only
found in strains within the genera Pediococcus (12.5%)
and Weissella (6.7%). The genes involved in the horizontal
transfer of resistance to tetracycline [tet(K), tet(L) and tetTable 5 MICs distribution of 10 antibiotics for the 9 enteroco
Antibiotics Number of strains with the indi
0.06 0.12 0.25 0.5 1 2 4 8 16 32




Streptomycin 1 3 5





aMICs determined by a VetMIC test. The antibiotic dilution ranges were: 0.25-32 mg
mg/L (kanamycin), 8-1024 mg/L (streptomycin), 0.5-64 mg/L (erythromycin, tetracyc
which exceeded the upper or lower limit of the tested range are listed in the next d
bLAB with MICs higher than the EFSA breakpoints are considered as resistant strain(M)], kanamycin [aac(6´ )-Ie-aph(2´ ´ )-Ia] and erythro-
mycin [erm(A), erm(B) and erm(C)] were not detected.
However, P. pentosaceus LPM78 and W. cibaria SMA25
harboured the erythromycin resistance gene mef(A/E).
The obtained amplicons were sequenced and found to
have 99% homology with the macrolide-efflux protein
(mefE) gene described for Streptococcus pneumoniae and
other Streptococcus spp. Moreover, P. pentosaceus LPM78
and LPM83 harboured the lnu(A) gene encoding the linco-
samide O-nucleotidyltransferase that inactivates lincomycin
and clindamycin. Sequencing of both amplicons showed
97% and 93% homology with lincosamide nucleotidyltrans-
ferase [lnu(A)] gene described for Staphylococcus haemoly-
ticus and S. aureus, respectively. Nevertheless, lnu(B) was
not detected in any of the tested strains. With regard
to E. faecium BNM58, which was phenotypically resistant
to erythromycin, none of the respective genes [erm(A),
erm(B), erm(C) and mef(A/E)] were detected.
Discussion
In this work, the antimicrobial activity against fish
pathogens and the in vitro safety of 99 LAB previously
isolated from fish, seafood and fish products [14] have
been assayed by using microbiological, biochemical and
genetic assays in order to identify and select the most
suitable candidates to be further evaluated as probiotics
for a sustainable aquaculture. LAB are widely known for
their ability to inhibit bacterial pathogens by the produc-
tion of antimicrobial compounds such as organic acids,
oxygen peroxide and ribosomally-synthesized peptides
referred to as bacteriocins, which constitutes a desirable
property for probiotics and a sustainable alternative to
antibiotics [9,18]. In this respect, most of the LAB of
aquatic origin tested in this work displayed a broad anti-
microbial spectrum against the main Gram-positive andccal strains
cated MIC (mg/L)a EFSA breakpoints (mg/L)b











/L (ampicillin), 1-128 mg/L (vancomycin), 2-256 mg/L (gentamicin), 16-2048
line and chloramphenicol), 0.25-16 mg/L (linezolid) and 0.12-16 (narasin). MICs
ilution series. MICs higher than the EFSA breakpoints are indicated in bold.
s [15]. n.a., not available.




Number of strains with the indicated MIC (mg/L)a EFSA
breakpoints
(mg/L)b
0.016 0.03 0.06 0.12 0.25 0.5 1 2 4 8 16 32 64 128 256 512 1024 2048
Ampicillin Lb. carnosus (2) 1 1 4
Lb. curvatus (1) 1 4
L. cremoris (3) 1 2 2




W. cibaria (15) 15 n.a.
Vancomycin Lb. carnosus (2) 2 n.r.
Lb. curvatus (1) 1 n.r.
L. cremoris (3) 3 4




W. cibaria (15) 15 n.a.
Gentamicin Lb. carnosus (2) 1 1 16
Lb. curvatus (1) 1 16
L. cremoris (3) 3 32
Lc. cremoris (3) 3 16
P. pentosaceus
(16)
1 1 9 3 2 16
W. cibaria (15) 6 7 1 1 n.a.
Kanamycin Lb. carnosus (2) 1 1 64
Lb. curvatus (1) 1 64
L. cremoris (3) 2 1 64
Lc. cremoris (3) 1 2 16
P. pentosaceus
(16)
1 13 2 64
W. cibaria (15) 1 1 4 4 4 1 n.a.
Streptomycin Lb. carnosus (2) 1 1 64
Lb. curvatus (1) 1 64
L. cremoris (3) 2 1 32
Lc. cremoris (3) 1 2 64
P. pentosaceus
(16)
1 5 10 64
W. cibaria (15) 2 7 5 1 n.a.
Erythromycin Lb. carnosus (2) 2 1
Lb. curvatus (1) 1 1
L. cremoris (3) 2 1 1
Lc. cremoris (3) 1 2 1
P. pentosaceus
(16)
1 4 7 3 1 1
W. cibaria (15) 9 5 1 n.a.
Clindamycin Lb. carnosus (2) 1 1 1
Lb. curvatus (1) 1 1
L. cremoris (3) 2 1 1
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Table 6 MICs distribution of 15 antibiotics for the 40 non-enterococcal strains (Continued)
Lc. cremoris (3) 2 1 1
P. pentosaceus
(16)
3 2 7 1 3 1
W. cibaria (15) 2 6 5 1 1 n.a.
Tetracycline Lb. carnosus (2) 1 1 8
Lb. curvatus (1) 1 8
L. cremoris (3) 1 1 1 4
Lc. cremoris (3) 1 2 8
P. pentosaceus
(16)
1 13 2 8
W. cibaria (15) 15 n.a.
Chloramphenicol Lb. carnosus (2) 1 1 4
Lb. curvatus (1) 1 4
L. cremoris (3) 1 2 8
Lc. cremoris (3) 3 4
P. pentosaceus
(16)
1 5 10 4
W. cibaria (15) 15 n.a.
Neomycin Lb. carnosus (2) 1 1 n.a.
Lb. curvatus (1) 1 n.a.
L. cremoris (3) 2 1 n.a.
Lc. cremoris (3) 3 n.a.
P. pentosaceus
(16)
1 9 4 2 n.a.
W. cibaria (15) 4 6 4 1 n.a.
Penicillin Lb. carnosus (2) 1 1 n.a.
Lb. curvatus (1) 1 n.a.
L. cremoris (3) 3 n.a.
Lc. cremoris (3) 1 2 n.a.
P. pentosaceus
(16)
7 8 1 n.a.
W. cibaria (15) 7 7 1 n.a.
Linezolid Lb. carnosus (2) 2 n.a.
Lb. curvatus (1) 1 n.a.
L. cremoris (3) 1 2 n.a.




W. cibaria (15) 15 n.a.
Ciprofloxacin Lb. carnosus (2) 2 n.a.
Lb. curvatus (1) 1 n.a.
L. cremoris (3) 2 1 n.a.




W. cibaria (15) 5 10 n.a.
Rifampicin Lb. carnosus (2) 1 1 n.a.
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Table 6 MICs distribution of 15 antibiotics for the 40 non-enterococcal strains (Continued)
Lb. curvatus (1) 1 n.a.
L. cremoris (3) 1 2 n.a.
Lc. cremoris (3) 1 2 n.a.
P. pentosaceus
(16)
2 13 1 n.a.
W. cibaria (15) 12 3 n.a.
Trimethoprim Lb. carnosus (2) 1 1 n.a.
Lb. curvatus (1) 1 n.a.
L. cremoris (3) 3 n.a.




W. cibaria (15) 15 n.a.
aMICs determined by a VetMIC test. The antibiotic dilution ranges were: 0.03-16 mg/L (ampicillin, clindamycin, penicillin and linezolid), 0.25-128 mg/L (vancomycin
and ciprofloxacin), 0.5-256 mg/L (gentamicin, streptomycin and neomycin), 2-1024 mg/L (kanamycin), 0.016-8 mg/L (erythromycin), 0.12-64 (tetracycline,
chloramphenicol, rifampicin and trimethoprim). MICs which exceeded the upper or lower limit of the tested range are listed in the next dilution series. MICs
higher than the EFSA breakpoints are indicated in bold.
bLAB with MICs higher than the EFSA breakpoints are considered as resistant strains [15]. n.r., not required; n.a., not available.
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high number of strains (24 out of 49 strains, 49%) were
identified as potential bacteriocin producers. Recently,
bacteriocin production ability has been proposed as a
key property for selection of probiotic LAB to be used in
aquaculture as an alternative to antibiotics to fight
against fish pathogen infections [19], similarly as pro-
posed for human and farm animal probiotics [20-22]. In
aquaculture farming, lactococcosis produced by the zoo-
notic agent L. garvieae, causing hemorrhagic septicaemia
and meningoencephalitis, is one of the most serious dis-
eases affecting several marine and fresh water fish spe-
cies [23]. With regard to this, our work shows that
putative bacteriocinogenic LAB active against this rele-
vant fish pathogen are common amongst the microbiota
isolated from aquatic animals (10 strains, 20%).
The application of probiotics in aquaculture may mod-
ify the microbial ecology of the aquatic hosts and their
surrounding environment, and thus the assessment of
their safety to the target aquatic species, the environ-
ment and humans constitutes an essential issue [24]. To
date, several studies describing the screening and evalu-
ation of LAB as probiotic candidates for aquaculture
have been reported [25-28]; however, the safety assess-
ment of the strains is generally limited to in vivo chal-
lenge tests and rearing trials in order to confirm their
lack of toxicity to the aquatic hosts [24,25,28-31]. Strik-
ingly, in vitro safety assessment studies have not been
generally addressed, despite they have lower economic
and ethic costs and result very effective to evaluate the
safety of a high number of candidate probiotic strains
not only for the host species, but also for humans and
the environment. According to EFSA [13], most of the
LAB species tested in this work (P. pentosaceus, Lb.curvatus, L. lactis, Lc. mesenteroides) are included in
the QPS list and, therefore, demonstration of their safety
only requires confirmation of the absence of determinants
of resistance to antibiotics of human and veterinary clinical
significance. However, in the case of enterococci, a more
thorough, strain-specific evaluation is required to assess the
risk associated to their intentional use in the food chain,
while no guidelines are given for the safety assessment of
the speciesW. cibaria [13].
Our results show that enterococcal virulence factors
were more frequently found in E. faecalis than in E.
faecium, which is in concordance with previous reports
[32-34]. In this respect, most of the E. faecalis (95%) and a
large percentage of the E. faecium (53%) strains evaluated
in this work showed, at least, one virulence factor, being
efaAfs, gelE and agg the most frequently detected genes.
With regard to gelE, which encodes for an extracellular
zinc endopeptidase that hydrolyzes gelatin, collagen,
hemoglobin, and other bioactive compounds, this gene
was detected at high frequency in E. faecalis, with all the
gelE+ strains showing gelatinase activity. However, five out
of nine E. faecium strains harbouring gelE were unable to
degrade gelatin, suggesting the carriage of a non-functional
gene, as previously reported [32,33]. Likewise, in the case of
E. faecium P68 and E. faecium GM29 harbouring cylLL-
cylLS, the lack of hemolytic activity may be explained by
the absence of cylM, whose product is involved in the post-
translational modification of cytolysin. On the other hand,
esp and hyl, which encode a cell wall-associated protein
involved in immune evasion and an hyaluronidase enzyme,
respectively, were not found in any of the tested LAB.
Previous studies have reported that esp and hyl are more
common in ampicillin-resistant/vancomycin-resistant E.
faecium (VREF) than in ampicillin-susceptible/VREF
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of VREF at hospital settings has been attributed mainly to
the spread of ampicillin-resistant VREF exhibiting esp
and/or hyl [36,37]. Therefore, the fact that the E. faecium
strains evaluated in this work lack these genes might be
related with their non-clinical origin and absence of ampi-
cillin resistance.
The use and frequent overuse of antibiotics, including
those used in human medicine, in fish farming has
resulted in the emergence and spread of antibiotic-
resistant bacteria in the aquaculture environment. This
possesses a threat to human and animal health due to
the increase of acquired antibiotic resistance in fish
pathogens, the transfer of their genetic determinants to
bacteria of terrestrial animals and to human pathogens,
and the alterations of the bacterial microbiota of the
aquatic environment [11,29]. In our study, the percent-
age of enterococcal strains showing acquired antibiotic
resistance was 68%. Interestingly, the results found in E.
faecium (71%) and E. faecalis (62%) were similar, how-
ever, higher percentages of resistance to ciprofloxacin
and/or norfloxacin, rifampicin, and glycopeptides were
observed in E. faecalis. Nevertheless, the occurrence of
erythromycin and tetracycline resistance was frequently
detected amongst E. faecium (45%) but only in one E.
faecalis strain (5%). In spite of the high prevalence of
acquired antibiotic resistance found in enterococci of
aquatic origin, they showed low incidence or absence
of resistance to the clinically relevant antibiotics vanco-
mycin (8.5%) and ampicillin, penicillin and gentamicin,
respectively, which is in agreement with previous studies
[33,38]. Moreover, the percentages of strains showing anti-
biotic resistance in the genera Weissella, Pediococcus and
Lactobacillus were 60, 44 and 33%, respectively, while none
of the leuconostocs and lactococci showed this phenotype.
In this regard, our results indicate that the LAB susceptibil-
ity patterns of MIC values to clinically relevant antibiotics
are species-dependent, similarly as previously described by
other authors [39,40]. Moreover, multiple antibiotic resist-
ance was commonly found in strains within the
genus Enterococcus (37%), mainly in E. faecalis, while being
very infrequent in the non-enterococcal strains (5%).
According to EFSA [29], the determination of MICs
above the established breakpoint levels, for one or more
antibiotic, requires further investigation to make the dis-
tinction between added genes (genes acquired by the
bacteria via gain of exogenous DNA) or to the mutation
of indigenous genes. According to our results, acquired
antibiotic resistance likely due to added genes is not a
common feature amongst the non-enterococcal LAB of
aquatic origin (7.5%). In this respect, this genotype was
only found in the genera Pediococcus (12.5%) and Weis-
sella (6.7%). Although P. pentosaceus LPV57 and LPM78
showed resistance to kanamycin (MIC of 128 mg/L), therespective resistance gene [aac(6´ )-Ie-aph(2´ ´ )-Ia] was
not found in these strains. Similarly, P. pentosaceus
TPP3 and SMF120 were phenotypically resistant to
tetracycline (MIC of 16 mg/L), but did not contain tet
(K), tet(L) or tet(M). In this respect, Ammor et al. [41]
reported that pediococci are intrinsically resistant to the
latter two antibiotics, as well as to glycopeptides (vanco-
mycin and teicoplanin), streptomycin, ciprofloxacin and
trimethoprim-sulphamethoxazole. Other authors proposed
a MIC for tetracycline in pediococci ranging between 8 and
16 mg/L [42], or of 32 mg/L for oxytetracycline in P.
pentosaceus [17]. The tetracycline breakpoints suggested
for pediococci by EFSA are lower than the MICs observed
in our work and others [17,42]. On the other hand, the
only antibiotic resistance detected in Leuconostoc strains
was for vancomycin, which is an intrinsic property of this
genus. It has been previously reported that Leuconostoc
strains display poor, if any, resistance to antibiotics of clin-
ical interest [38]. With regard to lactococci, the three L.
cremoris strains evaluated were susceptible to all the anti-
biotics; however, relatively high MICs for rifampicin (16–
32 mg/L) and trimethoprim (≥ 64 mg/L) were detected. In
fact, most lactococcal species are resistant to trimethoprim
[41]. As expected, all strains of heterofermentative Lacto-
bacillus spp. were resistant to vancomycin but susceptible
to the rest of the assayed antibiotics, except Lb. carnosus
B43, which showed the highest MIC for ampicillin and
penicillin (MICs of 8 and 4 mg/L, respectively). In this
context, the presence of modifications in the low affinity
penicillin-binding protein (PBP) that confers resistance to
penicillin and β-lactams in E. faecium and Streptococcus
pneumoniae, has been reported [43,44]. Moreover, nine
PBPs have been described in Lb. casei ATCC 393 [45],
which leads us to suggest that a similar mechanism may be
also responsible for the ampicillin and penicillin resistance
found in Lb. carnosus B43. The resistance to vancomycin
detected in Pediococcus, Leuconostoc and Lactobacillus
species in this study might be due to the presence of
D-Ala-D-Lactate in their peptidoglycan rather than
D-Ala-D-Ala dipeptide [46]. In this context, all tested W.
cibaria strains showed MICs ≥ 128 mg/L for vancomycin,
suggesting that vancomycin resistance is an intrinsic prop-
erty of this species. In relation to Weissella spp., studies on
antibiotic resistance profiles are very limited [47] and break-
points have not been defined by EFSA [15]. In our study,
most W. cibaria strains showed low MIC values; however
W. cibaria BCS50 showed relatively high MICs for penicil-
lin (8 mg/L) and kanamycin (64 mg/L), and W. cibaria
SMA25 showed MICs of 128 mg/L for kanamycin, 8 mg/L
for gentamicin, erythromycin and neomycin, and 2 mg/L
for clindamycin. Therefore, these two strains were dis-
carded of this study, while W. cibaria P50, P61, P64, P73,
SMA14, SDM381 and SDM389 were not included in the
final selection due to their MICs for kanamycin (32–
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we propose for W. cibaria the breakpoints assigned to
Leuconostoc spp. by EFSA [15], until further studies estab-
lish the wild-type MIC ranges within this species. In spite
of that, different MICs for rifampicin and trimethoprim for
W. cibaria and Lc. cremoris were found in this study. The
reduced susceptibility of W. cibaria towards trimethoprim
could indicate an intrinsic resistance to this antibiotic [48].
In our work, the only antibiotic resistance genes found were
mef(A/E), which encodes a drug efflux pump conferring a
low to moderate level of resistance to 14 (erythromycin and
clarithromycin)- and 15 (azithromycin)-membered macro-
lides but not to lincosamide or streptogramin B antibiotics
[49], and lnu(A), encoding the lincosamide O-nucleotidyl-
transferase that inactivates lincomycin and clindamycin
[50]. In this respect, P. pentosaceus LPM78 and W. cibaria
SMA25, displaying erythromycin resistance (MIC = 8
and ≥ 8 mg/L, respectively), carried the gene mef(A/E),
which can be found in a variety of Gram-positive bacteria,
including corynebacteria, enterococci, micrococci, and sev-
eral streptococcal species [51,52]. On the other hand, two
pediococci (P. pentosaceus LPM78 and LPM83) that
showed resistance to clindamycin (MIC = 4 and 2 mg/L, re-
spectively) carried the gene lnu(A), which had been only
previously found in staphylococci, streptococci, enterococci
and lactobacilli of animal origin and in staphylococci iso-
lated from humans [50,53]. Strikingly, the clindamycin re-
sistant strains P. pentosaceus LPP32 and B5 and W. cibaria
SMA25 (MIC = 4 and 2 mg/L, respectively) did not harbour
this gene nor lnu(B). To our knowledge, this is the first de-
scription of mef(A/E) in the genera Pediococcus and
Weissella, and lnu(A) in the genus Pediococcus. The detec-
tion of resistance genes for macrolide and lincosamide in
non-enterococcal strains suggests a wider distribution of
this group of genes than previously anticipated.
The in vitro subtractive screening proposed in this
work also include the assessment of bile salts deconjuga-
tion, mucin degradation, biogenic amine production and
other potentially detrimental enzymatic activities such as
the β-glucuronidase activity, which should be absent in
probiotic candidates [54-56]. Excessive deconjugation of
bile salts may be unfavourable in animal production
since unconjugated bile acids are less efficient than their
conjugated counterparts in the emulsification of dietary
lipids. In addition, the formation of micelles, lipid diges-
tion and absorption of fatty acids and monoglycerides
could be impaired by deconjugated bile salts [57]. Simi-
larly, excessive degradation of mucin may be harmful as
it may facilitate the translocation of bacteria to extrain-
testinal tissues [55]. In this respect, it is worthy to note
that none of the 49 tested LAB deconjugated bile salts
nor exhibited mucinolytic activity, the latter indicating
their low invasive and toxigenic potential at the mucosal
barrier. These results are in accordance with previousfindings showing that LAB do not degrade mucin
in vitro [58,59]. Moreover, β-glucuronidase activity has
been associated with the generation of potential carcino-
genic metabolites [56]; however, none of the LAB tested
in our study displayed this harmful enzymatic activity. In
a previous work [60], we demonstrated that none of the
40 non-enterococcal strains evaluated herein produced
histamine, tyramine or putrescine. With regard to en-
terococci, the nine E. faecium strains only produced tyr-
amine, being E. faecium CV1 a low producer of this
biogenic amine. Although the lack of biogenic amine
production by probiotic strains is a desirable trait, it
should be borne in mind that tyramine production by
enterococci is a very frequent trait [60,61]. Finally, sev-
eral studies have suggested that probiotic microorgan-
isms might exert a beneficial effect in the digestion
process of fish due to the production of extracellular
enzymes [62-65]. In our work, the LAB strains of aquatic
origin within the genera Pediococcus, Enterococcus and
Lactobacillus showed a higher number of enzymatic ac-
tivities than Lactococcus, Leuconostoc and Weissella,
being the enzymatic profiles similar amongst strains
within the same genus. In this respect, nearly all the
strains produced phosphatases, which might be involved
in nutrient absorption [64], and peptidases and glucosi-
dases that breakdown peptides and carbohydrates, re-
spectively. However, the tested LAB showed weak
lipolytic activity and no proteolytic activity.
Conclusions
This work shows that antimicrobial/bacteriocin activity
against fish pathogens is a widespread probiotic property
amongst LAB isolated from aquatic animals regarded as
human food. However, particular safety concerns based
on antibiotic resistances and virulence factors were dom-
inant within E. faecalis (100%) and E. faecium (79%), and
acquired antibiotic resistance genes were not commonly
found (7.5%; erythromycin and clindamycin) amongst
the non-enterococcal isolates of aquatic origin. To our
knowledge, this is the first large-scale study describing
the antimicrobial activity against fish pathogens and the
safety assessment beyond the QPS approach of LAB iso-
lated from aquatic animals. The in vitro subtractive screen-
ing presented herein, which allowed the selection of 33
strains (8 E. faecium, 11 P. pentosaceus, 1 Lb. carnosus, 1
Lb. curvatus, 3 L. cremoris, 3 Lc. cremoris and 6W. cibaria)
out of 99 LAB isolates of aquatic origin, constitutes a valu-
able strategy for the large-scale preliminary selection of pu-
tatively safe LAB intended for use as probiotics in
aquaculture and to avoid the spreading of bacterial cultures
with harmful traits into the aquatic environment. Neverthe-
less, a comprehensive in vivo assessment of their lack of
toxicity and undesirable effects must be also carried out
using cell lines, live food and, ultimately, aquatic animals
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a sustainable aquaculture.
Methods
Bacterial strains and growth conditions
A total of 99 LAB (59 enterococci and 40 non-enterococci)
of aquatic origin with antimicrobial activity against spoil-
age and food-borne pathogenic bacteria of concern for the
fish industry, previously isolated and identified by our
group from fish, seafood and fish products [14], were used
in this study (Table 1). The LAB strains were isolated on
non-supplemented MRS (Oxoid, Ltd., Basingstoke, United
Kingdom) or KAA (Oxoid) agar (1,5%, w/v) at 25°C, and
taxonomically identified [14] by sequencing of the genes
encoding 16S rRNA (16S rDNA) [66] and/or superoxide
dismutase (sodA) [67]. Unless otherwise stated, LAB were
grown aerobically in MRS broth at 32°C.
Direct antimicrobial activity assay
The antimicrobial activity of the 99 LAB against the
main Gram-positive and Gram-negative fish pathogens
was assayed by a qualitative stab-on-agar test (SOAT) as
previously described by Cintas et al. [68]. Briefly, pure
cultures were stabbed onto MRS or Tryptone Soya Agar
(TSA) (Oxoid) plates supplemented with glucose (2%, w/v)
and incubated at 32°C for 5 h, and then 40 ml of the corre-
sponding soft agar (0.8%, w/v) medium containing about
1 × 105 CFU/ml of the indicator strain was poured over the
plates. After incubation at 28-37°C for 16–24 h depending
on the indicator strain, the plates were checked for inhib-
ition zones (absence of visible microbial growth around the
stabbed cultures), and only inhibition halos with diameters
>3 mm were considered positive. L. garvieae JIP29-99 was
grown aerobically in Tryptone Soya Broth (TSB) (Oxoid) at
37°C. S. agalactiae CF01173 and S. iniae LMG14521 were
grown aerobically in Brain Heart Infusion (BHI) broth
(Oxoid) at 37°C. A. hydrophila CECT5734, Ls. anguillarum
CECT4344, Ls. anguillarum CECT7199, and Ph. damselae
CECT626 strains were grown aerobically in TSB at 28°C. V.
alginolyticus CECT521 was grown aerobically in TSB sup-
plemented with NaCl (1%, w/v; Panreac Química S.A.U,
Barcelona, Spain) at 28°C.
Extracellular antimicrobial activity assay
The antimicrobial activity of supernatants from LAB
cultures grown in MRS broth at 32°C for 16 h was deter-
mined by an agar well-diffusion test (ADT) as previously
described by Cintas et al. [68]. Supernatants were
obtained by centrifugation of cultures at 10,000 × g at 4°C
for 10 min, adjusted to pH 6.2 with 1 M NaOH, filter-
sterilized through 0.22 μm-pore-size filters (Millipore Corp.,
Bedford, Massachussets, USA) and stored at −20°C until
use. Fifty-μl aliquots of cell-free culture supernatants were
placed into wells (6-mm diameter) cut in cooled MRSor TSB agar (0.8%, wt/vol) plates previously seeded
(1 × 105 CFU/ml) with the indicator microorganisms
Pediococcus damnosus CECT4797, L. garvieae JIP29-99
or A. hydrophila CECT5734. After 2 h at 4°C, the plates
were incubated under the same conditions mentioned
above to allow for the growth of the target microorganisms
and then analyzed for the presence of inhibition zones
around the wells. To determine the proteinaceous nature of
the antimicrobial compounds, supernatants showing anti-
microbial activity were subjected to proteinase K treatment
(10 mg/ml) (AppliChem GmbH, Germany) at 37°C for 2 h.
After proteinase K inactivation by heat treatment (100°C,
10 min), samples were assayed for residual antimicrobial ac-
tivity by an ADT as described above using P. damnosus
CECT4797 as indicator microorganism. Supernatants with
no added enzyme were treated as indicated above and used
as controls. For further characterization of the antimicrobial
compounds, 7 ml of supernatants from an overnight cul-
ture of LAB were subjected to peptide concentration by
ammonium sulphate precipitation. Ammonium sulphate
was gradually added to the supernatants to achieve 50% sat-
uration. Samples were kept at 4°C with stirring for 3 h, and
then centrifuged at 10,000 × g at 4°C for 30 min. Pellets and
floating solid material were combined and solubilized in
350 μl of 20 mM sodium phosphate (pH 6.0), and anti-
microbial activity of the resulting 20-fold concentrated
supernatants was determined by an ADT as described
above.
PCR detection of potential virulence factors in enterococci
Detection of genes encoding potential virulence factors
in the 59 enterococci was performed by PCR. The fol-
lowing primer pairs were used: TE3/TE4 for detection of
agg (aggregation substance), TE9/TE10 for gelE (gelati-
nase), TE34/TE36 for esp (enterococcal surface protein),
TE5/TE6 for efaAfs (Enterococus faecalis endocarditis
antigen) [32], HYLn1/HYLn2 for hyl (hyaluronidase)
[35], CYLLL–R1/CYLLS–R2 for cylLL–cylLS (cytolysin
precursor) [69], and RHCT1/RHCT2 for cylLL–cylLS-cylM
(cytolysin precursor and posttranslational modifier) [70].
Oligonucleotide primers were obtained from Sigma-
Genosys Ltd. (Cambridge, United Kingdom). The positive
control strains for detection of potential virulence factors
were the following: E. faecalis P4 for cylLL–cylLs, cylLL–
cylLS–cylM, agg, gelE and efaAfs, E. faecalis P36 for esp
[32], and E. faecium C68 for hyl [35]. PCR-amplifications
were performed from total bacterial DNA obtained using
the Wizard DNA Purification Kit (Promega, Madrid,
Spain) in 25 μl reaction mixtures with 1 μl of purified
DNA, 0.7 μM of each primer, 0.2 mM of each dNTP, buf-
fer 1×, 1.5 mM MgCl2 and 0.75 U of Platinum Taq DNA
polymerase (Invitrogen, Madrid, Spain). Samples were
subjected to an initial cycle of denaturation (97°C for
2 min), followed by 35 cycles of denaturation (94°C for
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for 30 to 180 s), ending with a final extension step at 72°C
for 7 min in an Eppendorf Mastercycler thermal cycler
(Eppendorf, Hamburg, Germany). PCR products were ana-
lyzed by electrophoresis on 1-2% (w/v) agarose (Pronadisa,
Madrid, Spain) gels stained with Gel red (Biotium, California,
USA), and visualized with the Gel Doc 1000 documentation
system (Bio-Rad, Madrid, Spain). The molecular size mar-
kers used were HyperLadder II (Bioline GmbH, Germany)
and 1Kb Plus DNA ladder (Invitrogen).
Production of gelatinase by enterococci
Gelatinase production was determined using the method
previously described by Eaton and Gasson [32]. Briefly, en-
terococci were grown in MRS broth overnight at 32°C, and
streaked onto Todd-Hewitt (Oxoid) agar plates (1.5%, w/v)
containing 30 g of gelatine per litre. After incubation
overnight incubation at 37°C, the plates were placed
at 4°C for 5 h before examination for zones of turbidity
(protein hydrolysis) around the colonies. E. faecalis P4
was used as positive control.
Production of hemolysin
To investigate hemolysin production by the 99 LAB, the
strains grown in MRS broth were streaked onto layered
fresh horse blood agar plates (BioMérieux, Marcy l'Étoile,
France) and grown at 37°C for 1–2 days [32]. β-hemolysis
was revealed by the formation of clear zones surrounding
the colonies on blood agar plates. E. faecalis P4 was used as
positive control.
Determination of antibiotic susceptibility
Antibiotic susceptibility of the 59 enterococci was deter-
mined by overlaying antibiotic-containing disks (Oxoid)
on Diagnostic Sensitivity Test Agar (Oxoid) previously
seeded with approximately 1 × 105 CFU/ml of each
enterococcal isolate. The antibiotics tested were ampicil-
lin (10 μg), chloramphenicol (30 μg), ciprofloxacin (5 μg),
erythromycin (15 μg), gentamicin (120 μg), nitrofurantoin
(300 μg), norfloxacin (10 μg), penicillin G (10 IU), rifampi-
cin (5 μg), teicoplanin (30 μg), tetracycline (30 μg), and
vancomycin (30 μg). Inhibition zone diameters were mea-
sured after overnight incubation of the plates at 37°C.
Resistance phenotypes were recorded as recommended by
the Clinical and Laboratory Standards Institute [71]. E. fae-
calis CECT795 and Staphylococcus aureus CECT435 were
used for quality control. The minimum inhibitory concen-
tration for the 49 pre-selected LAB was determined by a
broth microdilution test using e-cocci (for enterococci),
and Lact-1 and Lact-2 (for non-enterococcal strains)
VetMIC microplates (National Veterinary Institute, Upp-
sala, Sweden). The antibiotics evaluated for enterococci
were ampicillin, vancomycin, gentamicin, kanamycin,
streptomycin, erythromycin, tetracycline, chloramphenicol,narasin, and linezolid, while for the non-enterococcal
strains, the tested antibiotics were ampicillin, vancomycin,
gentamicin, kanamycin, streptomycin, erythromycin, clin-
damycin, tetracycline, chloramphenicol, neomycin, penicil-
lin, linezolid, ciprofloxacin, rifampicin, and trimethoprim.
Individual colonies were suspended in a sterile glass tube
containing 5 ml saline solution (0.85% NaCl) to a turbidity
of 1 in the McFarland scale (approx. 3 × 108 CFU/ml) and
further diluted 1000-fold. Iso-sensitest (IST) broth (Oxoid)
was used for enterococci, while LSM medium (IST:MRS,
9:1) was used for all the non-enterococcal strains ex-
cept Lactobacillus curvatus subsp. curvatus BCS35,
that required LSM broth supplemented with 0.03% (w/v)
L-cysteine (Merck KGaA) [72]. Fifty or 100 μl of the diluted
enterococcal and non-enterococcal suspensions, respect-
ively, was added to each microplate well which was then
sealed with a transparent covering tape and incubated at
37°C for 18 h (in the case of Lb. curvatus BCS35, the plates
were incubated anaerobically at 32°C for 18 h). After incu-
bation, MICs were established as the lowest antibiotic
concentration that inhibited bacterial growth, and inter-
preted according to the breakpoints identified by the FEE-
DAP Panel and adopted by EFSA to distinguish between
susceptible and resistant strains [15]. Accordingly, strains
showing MICs higher than the respective breakpoint were
considered as resistant. E. faecalis CECT795 and S. aureus
CECT794 were used for quality control of e-cocci, and
Lact-1 and Lact-2 VetMIC microplates, respectively.
Deconjugation of bile salts
The ability of the 49 pre-selected LAB to deconjugate
primary and secondary bile salts was determined accord-
ing to Noriega et al. [73]. Bile salt plates were prepared
by adding 0.5% (w/v) sodium salts of taurocholate (TC)
and taurodeoxycholate (TDC) (Sigma-Aldrich Corpor-
ation, St. Louis, Missouri, USA) to MRS agar (1.5%, w/v)
supplemented with 0.05% (w/v) L-cysteine (Merck
KGaA, Darmstadt, Germany). Overnight liquid cultures
of strains (10 μl) were spotted onto agar plates and incu-
bated under anaerobic conditions (Anaerogen, Oxoid) at
37°C for 72 h. The presence of precipitated bile acid
around the colonies (opaque halo) was considered as a
positive result. A fresh fecal slurry of a healthy adult
horse was used as positive control for bile salts deconju-
gating activities.
Degradation of mucin
The capacity of the 49 pre-selected LAB to degrade gas-
tric mucin was determined as described by Zhou et al.
[58]. Mucin from porcine stomach type III (Sigma-
Aldrich Corp.) and agar were added to medium B with-
out glucose at concentrations of 0.5% (w/v) and 1.5% (w/v),
respectively. A volume of 10 μl of 24 h viable bacterial cul-
tures was inoculated onto the surface of medium B. The
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quently stained with 0.1% (w/v) amido black (Merck KGaA)
in 3.5 M acetic acid for 30 min, and then washed with
1.2 M acetic acid (Merck KGaA). A discoloured zone
around the colony was considered as a positive result. A
fresh fecal slurry of a healthy adult horse was used as posi-
tive control for mucin degradation ability.Determination of enzymatic activities
The APIZYM test (BioMérieux, Montallieu Vercieu,
France) was used for determination of enzymatic activ-
ities of the 49 pre-selected LAB. Cells from cultures grown
at 32°C overnight were harvested by centrifugation at
12,000 g for 2 min, resuspended in 2 ml of API Suspension
Medium (BioMérieux) and adjusted to a turbidity of 5–6
in the McFarland scale (approx. 1.5-1.9 × 109 CFU/ml).
Aliquots of 65 μl of the suspensions were added to each of
the 20 reaction cupules in the APIZYM strip. The strips
were incubated at 37°C for 4.5 h and the reactions were
developed by addition of one drop each of the APIZYM
reagents A and B. Enzymatic activities were graded from 0
to 5, and converted to nanomoles as indicated by the
manufacturer´ s instructions.PCR detection of antibiotic resistance genes
The presence of genetic determinants conferring re-
sistance to aminoglycosides except streptomycin [aac
(6´)-Ie-aph(2´´)-Ia], to erythromycin [erm(A), erm(B), erm
(C) and mef(A/E)], to tetracycline [tet(K), tet(L) and tet
(M)], and to lincosamides [lnu(A) and lnu(B)] was deter-
mined by PCR in the LAB strains showing antibiotic
resistance by the VetMIC assay. PCR-amplifications and
PCR-product visualization and analysis were performed as
described above using the following primer-pairs: aacF/
aacR for detection of aac(6´)-Ie-aph(2´´)-Ia [74], ermAI/
ermAII for erm(A) [75,76], ermBI/ermBII for erm(B) [17],
ermCI/ermCII for erm(C) [17,77], mef(A/E)I/ mef(A/E)II
for mef(A/E) [75,76], tetKI/ tetKII for tet(K) [17], tetLI/
tetLII for tet(L) [17,78], tetMI/tetMII for tet(M) [17,78],
lnuA1/lnuA2 for lnu(A) [79], lnuB1/lnuB2 for lnu(B) [50].
E. faecalis C1570 was used as positive control for amplifica-
tion of erm(C), lnu(A) and tet(K) and E. faecalis C1231 for
erm(A). E. faecium 3Er1 (clonal complex of hospital-
associated strain CC9) and E. faecium RC714 were used as
positive controls for amplification of aac(6´)-Ie-aph(2´´)-Ia,
tet(M) and tet(L), and for erm(B) and mef(A/E), respect-
ively. The amplicons obtained with mef(A/E) and lnu(A)
specific primers were purified by using the NucleoSpin Ex-
tract II Kit (Macherey-Nagel GmbH & Co. KG, Düren,
Germany) and both DNA strands were sequenced at the
Unidad de Genómica (Parque Científico de Madrid, Facul-
tad de Ciencias Biológicas, Universidad Complutense de
Madrid, Spain). Analysis of DNA sequences was performedwith the BLAST program available at the National Center
for Biotechnology Information (NCBI).
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